SeaStar Medical
ICU

$8.80

15.07%

Market Cap: 36.7M

About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Employees: 12

Healthcare Surgical & Medical Instruments & Apparatus

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

0

News positive %

of 79 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

571% more capital invested

Capital invested by funds: $418K [Q4 2023] → $2.8M (+$2.38M) [Q1 2024]

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

21% more funds holding

Funds holding: 24 [Q4 2023] → 29 (+5) [Q1 2024]

3.64% more ownership

Funds ownership: 2.21% [Q4 2023] → 5.85% (+3.64%) [Q1 2024]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ICU.

See Analyst Rankings

Financial journalist opinion

Based on 79 articles about ICU published over the past 30 days

ICU Investors Can Lead Seastar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ: ICU ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.

ICU Investors Can Lead Seastar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment inSeaStar Medical Holding Corporationof Class Action Lawsuit and Upcoming Deadlines– ICU

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation (“SeaStar” or the “Company”) (NASDAQ: ICU) and certain officers. The class action, filed in the United States District Court for the District of Colorado, and docketed under 24-cv-01873, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired SeaStar securities between October 31, 2022 and March 26, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment inSeaStar Medical Holding Corporationof Class Action Lawsuit and Upcoming Deadlines– ICU

ICU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit

NEW YORK CITY, NY / ACCESSWIRE / July 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU)(NASDAQ:ICUCW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Seastar securities between October 31, 2022, and March 26, 2024, inclusive (the "Class Period").

ICU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit

ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit

NEW YORK , July 25, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), of the important September 6, 2024 lead plaintiff deadline. So what: If you purchased SeaStar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit

ICU Investors Can Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ: ICU ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.

ICU Investors Can Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

ICU; ICUCW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Seastar Medical Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. (“Seastar” or “the Company”) (NASDAQ: ICU; ICUCW) and certain of its officers.

ICU; ICUCW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Seastar Medical Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Stockholders Have Opportunity to Lead Class Action Lawsuit

NEW YORK CITY, NY / ACCESSWIRE / July 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Seastar Medical Holding Corp. ("Seastar" or "the Company") (NASDAQ:ICU)(NASDAQ:ICUCW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Seastar securities between October 31, 2022, and March 26, 2024, inclusive (the "Class Period").

ICU INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Seastar Medical Holding Corp. Stockholders Have Opportunity to Lead Class Action Lawsuit

ICU Investors Can Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation ("SeaStar" or "the Company") (NASDAQ: ICU ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 6, 2024.

ICU Investors Can Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit With The Schall Law Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU

NEW YORK , July 24, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against SeaStar Medical Holding Corporation ("SeaStar" or the "Company") (NASDAQ: ICU) and certain officers. The class action, filed in the United States District Court for the District of Colorado, and docketed under 24-cv-01873, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired SeaStar securities between October 31, 2022 and March 26, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU

ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 24, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SeaStar Medical Holding Corporation (“SeaStar” or “the Company”) (NASDAQ: ICU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2022 and March 26, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before September 6, 2024.

ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm

See News Rankings